Monographie - Diamorphine hydrochloride

Utolsó frissítés :
18/04/2024

Diamorphine hydrochloride

Kémiai szerkezet

Kereskedelmi név

A kereskedelmi név meghatározó jelentőségű: a készítmények összetétele országonként, előállítóként eltérő lehet

Diamorphine hydrochloride for injection	Nagy-Britannia
Diaphin	Svájc

Irodalom : Diamorphine hydrochloride

	Type	Publikáció
339	Napló	Kleinberg ML, Duafala ME, Nacov C, Flora KP, Hines J, Davis K, McDaniel A, Scott D. Stability of heroin hydrochloride in infusion devices and containers for intravenous administration. Am J Hosp Pharm 1990 ; 47: 377-381.
484	Napló	Northcott M, Allsopp MA, Powell H, Sewell GJ. The stability of carboplatin, diamorphine, 5-fluorouracil and mitozantrone infusions in an ambulatory pump under storage and prolonged “in use” conditions. J Clin Pharm Ther 1991 ; 16: 123-129.
506	Napló	Omar OA, Hoskin PJ, Johnston A, Hanks W, Turner P. Diamorphine stability in aqueous solution for subcutaneous infusion. J Pharm Pharmacol 1989 ; 41: 275-277.
512	Napló	Barnes AR, Nash S. Stability of bupivacaine hydrochloride with diamorphine hydrochloride in an epidural infusion. Pharm World Sci 1995 ; 17: 87-92.
779	Napló	Collins AJ, Abethell JA, Holmes SG, Rain R. Stability of diamorphine hydrochloride with haloperidol in prefilled syringes for continuous subcutaneous administration. J Pharm Pharmacol 1986 ; 38: 51P.
788	Napló	Regnard CFB, Mannix K. Subcutaneous drug compatibility in palliative care. Lancet 1989 ; 2 (8670): 1044-1045.
1230	Napló	Regnard C, Pashley S, Westrope F. Anti-emetic / diamorphine mixture compatibility in infusion pumps. Br J Pharm Pract 1986 ; 8: 218-220.
1232	Napló	Beatson C, Taylor A. A physical compatibility study of furosemide & flucloxacillin injections. Br J Pharm Pract 1987 ; 9: 223-226, 236.
1288	Napló	Allwood MC, Brown PW, Lee M. Stability of injections containing diamorphine and midazolam in plastic syringes. Int J Pharm Pract 1994 ; 3: 57-59.
1292	Napló	Grassby PF, Roberts DE. Stability of epidural opiate solutions in 0.9 per cent sodium chloride infusion bags. Int J Pharm Pract 1995 ; 3: 174-177.
1385	Napló	Kirk B, Hain WR. Diamorphine injection BP incompatibility. Pharm J 1985 ; 235: 171.
1388	Napló	Page J, Hudson S. Diamorphine hydrochloride compatibility with saline. Pharm J 1982 ; 228: 238-239.
1886	Napló	Allwood MC. The stability of diamorphine alone and in combinaison with antiemetics in plastic syringes. Palliative Med 1991 ; 5: 330-333.
2051	Napló	Sanchez del Aguila MJ, Jones MF, Vohra A. Premixed solutions of diamorphine in ropivacaine for epidural anaesthesia: a study on long-term stability. Br J Anaesth 2003 ; 90: 179-182.
2307	Napló	Kreeger L, Cowin P, Noble-Gresty J, Naysmith A. Epidural diamorphine and bupivacaine stability study. Palliative Med 1995 ; 9, 4: 315-318.
2308	Napló	Hudson S.J, Jones M.F, Nolan S, Ellis H, Duncombe R, Alexander-Williams J.M. Stability of premixed syringes of diamorphine and hyperbaric bupivacaine. Int J Obstet Anesth 2005 ; 14, 4: 284-287.
2404	Napló	Fielding H, Kyaterekera , Skellern GG, Tettey JN, McDade JR, ZMsuya Z, Watson DG, Urie J. The compatibility and stability of octreotide acetate in the presence of diamorphine hydrochloride in polypropylene syringes Palliative Med 2000 ; 14: 205-208.
3184	Laboratórium	Hyaluronidase (Hyalase®) - Summary of Product characteristics. CP Pharmaceuticals 2005
3504	Laboratórium	Parecoxib (Dynastat®) - Summary of Product Characteristics Pfizer 2012

Mentions Légales